As the market transitions from a fearful tone to bullish optimism, some stocks may struggle to keep up, underperforming even ...

Beyond Inc. is on of our top picks for 2025. Why do we believe analyst FY25 revenue estimates are overly pessimistic? Click ...

Investors looking for growth in a reversal market may find the stock underperforming, as the change in trend is difficult to ignore. Therefore, it is wise to tread carefully with this one during ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

After showing a sustainable up move in the last four sessions, the Nifty witnessed high volatility on the day of the ...

Booz Allen Hamilton showed a strong reversal in EBITDA performance from the previous quarter. Find out my recommendation for ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common ...

Markets across Asia staged a relief rally after President Trump postponed tariffs on Canada and Mexico. Both Japanese and ...

The Company anticipates that the reverse stock split will increase the market price per share of the Company’s common stock, bringing the Company into compliance with The Nasdaq Capital Market ...

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...